Nature of Operations, Basis of Presentation and Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2021

Accounting Policies [Abstract]

Schedule of Fair Value Measurements

	Fair Value Measurements at September 30, 2021
	Quoted Prices in Active Markets for Identical Assets		Other Observable Inputs		Significant Unobservable Inputs
(in thousands)	(Level 1)		(Level 2)		(Level 3)		Total
Derivative liability	$	-	$	-	$	3,475	$	3,475
Total	$	-	$	-	$	3,475	$	3,475

Schedule of Roll Forward of Level 3 Financial Instruments

A roll forward of the level 3 valuation financial instruments is as follows:

	Nine months Ended September 30, 2021
(In thousands)	Warrants		Notes			Total
Balance at December 31, 2020	$	—	$	—		$	—
Initial valuation of derivative liabilities included in debt discount		—		223			223
Initial valuation of derivative liabilities included in derivative expense		—		619			619
Reclassification of derivative liabilities to gain on debt extinguishment		—		(92	)		(92	)
Reclass from Additional paid-in capital		46		244			290
Change in fair value included in derivative expense		361		2,074			2,435
Balance at September 30, 2021	$	407	$	3,068		$	3,475

Schedule of Earnings Per Share, Basic and Diluted

The following table presents the computation of net loss per share (in thousands, except share and per share data):

	Three Months Ended September 30,						Nine Months Ended September 30,
	2021			2020			2021			2020
Numerator
Net loss	$	(3,739	)	$	(539	)	$	(4,682	)	$	(3,283	)
Dividends		(406	)		(388	)		(1,679	)		(1,153	)
Net Loss allocable to common stockholders	$	(4,145	)	$	(927	)	$	(6,361	)	$	(4,436	)
Denominator
Weighted average common shares outstanding used to compute net loss per share, basic and diluted		12,986,391			10,869,530			11,742,315			10,869,530
Net loss per share of common stock, basic and diluted
Net loss per share	$	(0.32	)	$	(0.09	)	$	(0.54	)	$	(0.41	)

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

Potentially dilutive securities not included in the calculation of diluted net loss per common share because to do so would be anti-dilutive are as follows:

	2021		2020
Convertible Notes		24,332,784		23,690,018
Stock options outstanding		387,550		1,216,350
Warrants		61,306,350		69,047,000
Series C Preferred Stock		66,667		66,667
Series D Preferred Stock		50,000		50,000
Series E Preferred Stock		43,514,922		41,597,256
Series F Preferred Stock		4,519,872		4,230,973
Total		134,178,046		139,898,264